Angiogenesis Scaffolding

Information

  • Research Project
  • 6693123
  • ApplicationId
    6693123
  • Core Project Number
    R43HL074638
  • Full Project Number
    1R43HL074638-01
  • Serial Number
    74638
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/2003 - 22 years ago
  • Project End Date
    2/28/2005 - 20 years ago
  • Program Officer Name
    IKEDA, RICHARD A.
  • Budget Start Date
    9/1/2003 - 22 years ago
  • Budget End Date
    2/28/2005 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/1/2003 - 22 years ago
Organizations

Angiogenesis Scaffolding

DESCRIPTION (provided by applicant): NanoMatrix, Inc and investigators at Virginia Commonwealth University (VCU) propose to use the process of electrospinning to fabricate electrospun collagen scaffolding designed to promote tissue regeneration. Ultimately, we believe this type of scaffold will serve as a solid-phase platform for the delivery of a variety of peptide factors and other agents to specific injury sites. Electrospinning has several distinct advantages; it is rapid and remarkably efficient. Electrospun fibrils of collagen appear to recapitulate many of the structural and functional properties of the native collagen fibril. Fibrils of electrospun collagen are 50-150 nm in diameter and exhibit a 65 nm repeat. To date this ultrastructural feature has not been reproduced in collagen fibrils that have been fabricated or otherwise polymerized in vitro by standard methods. This structural feature has only been observed in collagen deposited by cellular activity. An electrospun matrix of collagen is highly porous, will accept a suture, and is rapidly infiltrated by microvascular endothelial cells, events critical to the tissue-regeneration process. In preliminary experiments we demonstrate that it is possible to co-electrospin collagen and the growth factor vascular endothelial growth factor (VEGF) into a tissue-engineering scaffolding. This peptide is released from the collagen-based matrix over time and retains biological activity. When implanted, a VEGF-supplemented scaffolding is rapidly infiltrated by microvascular endothelial cells, functional capillaries. The Specific Aims of this Project are: Specific Aim 1. Tailor the controlled release of VEGF from an electrospun scaffold composed of Type I collagen and a PGNPLA copolymer blend. Specific Aim 2. Test electrospun scaffoldings supplemented with VEGF for angiogenic activity in the rabbit cornea.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    124521
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:124521\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NANOMATRIX, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BATON ROUGE
  • Organization State
    LA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    70894
  • Organization District
    UNITED STATES